PLA2G4F

Chr 15

phospholipase A2 group IVF

Also known as: PLA2G4FZ

Predicted to enable calcium ion binding activity; calcium-dependent phospholipid binding activity; and obsolete calcium-dependent phospholipase A2 activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within arachidonate secretion; cellular response to antibiotic; and prostaglandin biosynthetic process. Predicted to be located in mitochondrion and plasma membrane. Predicted to be active in cytosol; ruffle membrane; and vesicle. [provided by Alliance of Genome Resources, Jun 2026]

ResearchGenerating clinical summary…
0
Active trials
8
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.17
LOEUF
GOF
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.17LOEUF
pLI 0.000
Z-score 0.60
OE 0.91 (0.71–1.17)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.53Z-score
OE missense 1.07 (0.99–1.15)
530 obs / 496.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.91 (0.71–1.17)
0≤0.351.4
Missense OE?1.07 (0.99–1.15)
0≤0.61.4
Synonymous OE?1.01
0≤1.21.6
LoF obs/exp: 44 / 48.5Missense obs/exp: 530 / 496.6Syn Z: -0.15

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PLA2G4F · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →